Glioblastoma Immunotherapy Advancement with Nivolumab and Relatlimab

Clinical Trial Grant

Duke Scholars

Principal Investigator Mustafa Khasraw Neurosurgery

Awarded By

Bristol-Myers Squibb Company

Start Date

November 25, 2024

End Date

June 30, 2029

Awarded By

Bristol-Myers Squibb Company

Start Date

November 25, 2024

End Date

June 30, 2029